Opportunity ID: 177933

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-AI-12-023
Funding Opportunity Title: Development of Medical Countermeasures for Post-Exposure Mitigation/Treatment of Injuries Resulting from a Radiation/Nuclear Incident (U01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.855 — Allergy, Immunology and Transplantation Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jun 19, 2012
Last Updated Date:
Original Closing Date for Applications: Oct 18, 2012
Current Closing Date for Applications: Oct 18, 2012
Archive Date: Nov 18, 2012
Estimated Total Program Funding: $4,000,000
Award Ceiling: $350,000
Award Floor:

Eligibility

Eligible Applicants: Independent school districts
Native American tribal governments (Federally recognized)
For profit organizations other than small businesses
Special district governments
State governments
Public housing authorities/Indian housing authorities
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Private institutions of higher education
County governments
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: To support research on: 1) further development of candidate medical countermeasures with post-radiation exposure administration data showing efficacy to mitigate and/or treat radiation injury, including acute radiation syndromes, and/or the delayed effects of acute radiation exposure; and 2) elucidation of mechanisms of action of candidate medical countermeasures, necessary to meet product licensure requirements.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-12-023.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
ADOBE-FORMS-B2 Adobe-Forms-B2 PKG00127910 Sep 18, 2012 Oct 18, 2012 View

Package 1

Mandatory forms

177933 RR_SF424_1_2-1.2.pdf

177933 PerformanceSite_1_4-1.4.pdf

177933 RR_OtherProjectInfo_1_3-1.3.pdf

177933 RR_KeyPersonExpanded_1_2-1.2.pdf

177933 PHS398_CoverPageSupplement_1_4-1.4.pdf

177933 PHS398_ResearchPlan_1_3-1.3.pdf

177933 PHS398_Checklist_1_3-1.3.pdf

Optional forms

177933 RR_SubawardBudget30-1.2.pdf

177933 PHS398_ModularBudget_1_2-1.2.pdf

177933 RR_Budget-1.1.pdf

177933 PHS_CoverLetter_1_2-1.2.pdf

2025-07-10T18:19:05-05:00

Share This Post, Choose Your Platform!

About the Author: